Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Diagnostic Value of FDG-PET and HMPAO-SPET in Patients with Mild Dementia and Mild Cognitive Impairment: Metabolic Index and Perfusion Index

View through CrossRef
<i>Objective:</i> The diagnostic potential of F-18-2-fluoro-2-deoxy-<i>D</i>-glucose positron emission tomography (PET) and technetium-99m hexamethylpropylene amine oxime single-photon emission tomography (SPET) in early detection and differential diagnosis of early dementia was evaluated including a comparison of metabolic and perfusion indices (PI). <i>Methods:</i> Twenty-four patients with initial clinical suspicion of beginning dementia were examined, 12 of them with mild cognitive impairment. All patients underwent SPET and PET within 2 weeks. Data were compared with the final clinical diagnosis at follow-up – 9 with Alzheimer’s disease (AD), 1 with frontotemporal dementia, 1 with vascular dementia (VD), 7 with mixed type of dementia (MIX) and 6 without any type of dementia. Metabolic indices (MI) and PI were compared with each other. The regional cerebral blood flow difference (rCBFdiff) calculated as local uptake difference between the right and left hemisphere was measured for patients with VD and MIX. <i>Results:</i> PET showed higher sensitivity and specificity in identifying the different types of early dementia (44–91 and 78–89%, respectively) than SPET (11–64 and 79–89%, respectively), especially in detecting AD (sensitivity 44%, specificity 83%) and MIX (sensitivity 71%, specificity 78%). Especially in patients with mild cognitive impairment, PET was the superior imaging modality for predicting dementia. Using PET, dementia could be excluded in all patients who did not develop dementia during the follow-up. In all patients, a weak correlation between PI and MI was observed (rho = 0.64, p < 0.002). The rCBFdiff in patients with VD and MIX ranged from 7 to 37%. <i>Conclusion:</i> In this study on patients with initial suspicion of beginning dementia who underwent both imaging modalities, PET and SPET, PET was the superior imaging method, especially in the detection of early AD or MIX.
Title: Diagnostic Value of FDG-PET and HMPAO-SPET in Patients with Mild Dementia and Mild Cognitive Impairment: Metabolic Index and Perfusion Index
Description:
<i>Objective:</i> The diagnostic potential of F-18-2-fluoro-2-deoxy-<i>D</i>-glucose positron emission tomography (PET) and technetium-99m hexamethylpropylene amine oxime single-photon emission tomography (SPET) in early detection and differential diagnosis of early dementia was evaluated including a comparison of metabolic and perfusion indices (PI).
<i>Methods:</i> Twenty-four patients with initial clinical suspicion of beginning dementia were examined, 12 of them with mild cognitive impairment.
All patients underwent SPET and PET within 2 weeks.
Data were compared with the final clinical diagnosis at follow-up – 9 with Alzheimer’s disease (AD), 1 with frontotemporal dementia, 1 with vascular dementia (VD), 7 with mixed type of dementia (MIX) and 6 without any type of dementia.
Metabolic indices (MI) and PI were compared with each other.
The regional cerebral blood flow difference (rCBFdiff) calculated as local uptake difference between the right and left hemisphere was measured for patients with VD and MIX.
<i>Results:</i> PET showed higher sensitivity and specificity in identifying the different types of early dementia (44–91 and 78–89%, respectively) than SPET (11–64 and 79–89%, respectively), especially in detecting AD (sensitivity 44%, specificity 83%) and MIX (sensitivity 71%, specificity 78%).
Especially in patients with mild cognitive impairment, PET was the superior imaging modality for predicting dementia.
Using PET, dementia could be excluded in all patients who did not develop dementia during the follow-up.
In all patients, a weak correlation between PI and MI was observed (rho = 0.
64, p < 0.
002).
The rCBFdiff in patients with VD and MIX ranged from 7 to 37%.
<i>Conclusion:</i> In this study on patients with initial suspicion of beginning dementia who underwent both imaging modalities, PET and SPET, PET was the superior imaging method, especially in the detection of early AD or MIX.

Related Results

Baseline Staging Evaluation in Lymphoma: The Role of FDG PET, CT, and Bone Marrow Biopsy
Baseline Staging Evaluation in Lymphoma: The Role of FDG PET, CT, and Bone Marrow Biopsy
Abstract Abstract 2640 BACKGROUND: The revised response criteria for malignant lymphoma (Cheson et al JCO 25:579 ...
Has the 67Ga-SPET a Role in Monitoring Hodgkin and Primary Mediastinal Lymphoma in the PET-FDG Age?.
Has the 67Ga-SPET a Role in Monitoring Hodgkin and Primary Mediastinal Lymphoma in the PET-FDG Age?.
Abstract Background and aims Present data indicate that FDG-PET has a superior accuracy than gallium scan (Ga-S) in staging and post-therapy restaging...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
SEMANA DE ENFERMAGEM E SEUS ASPECTOS SOCIAIS NA VALORIZAÇÃO PROFISSIONAL: UM RELATO DE EXPERIÊNCIA DO GRUPO PET-ENFERMAGEM
SEMANA DE ENFERMAGEM E SEUS ASPECTOS SOCIAIS NA VALORIZAÇÃO PROFISSIONAL: UM RELATO DE EXPERIÊNCIA DO GRUPO PET-ENFERMAGEM
A enfermagem é o pilar da assistência pois está na linha de frente do cuidado holístico, todavia esta é estigmatizada e desvalorizada, assim como não possui reconhecimento consider...
Forced diuresis and dual-phase 18F-fluorodeoxyglucose-PET/CT scan for restaging of urinary bladder cancers
Forced diuresis and dual-phase 18F-fluorodeoxyglucose-PET/CT scan for restaging of urinary bladder cancers
Abstract Context: The results of 18 F-fluorodeoxyglucose (FDG)-PET imaging carried out with the current standard techniques for assessment of urinary tract cancers have...

Back to Top